mɔɹnɪŋ [morning//mourning]

An experimental opera inhabits a world in which all humans have disappeared from Earth. An ensemble of five vocalists/multi-instrumentalists witness and guide the audience through the changes on Earth as forests grow back, new species evolve, and the human-made world erodes away. The piece is a fantastical and playful exploration into the dire political and ethical contradictions that structure current human relations with nature.

*The performance on January 11th will be followed by an artist conversation.

Produced by HERE. Commissioned and developed through the HERE Artist Residency Program.

The development of mɔɹnɪŋ [morning//mourning] received funding from OPERA America’s Opera Grants for Female Composers program, supported by the Virginia B. Toulmin Foundation. Additional support provided by Augustine Foundation and The Puffin Foundation. Production design support provided by the Edith Lutyens and Norman Bel Geddes Design Enhancement Fund, a program of the Alliance of Resident Theatres/New York (A.R.T./New York). This program is supported, in part, by public funds from the New York City Department of Cultural Affairs in partnership with the City Council. The company debut of Tara Ahmadinejad was partially supported by OPERA America’s Opera Grants for Women Stage Directors and Conductors, generously funded by the Marineau Family Foundation.

Until further notice, all patrons attending HERE performances and events will be required to wear masks (KN95 or KF94 masks are strongly recommended). 

Proof of vaccination is no longer required.

We ask all audience members to please stay home if they have a sore throat, are feeling sick in any other way, or have been recently exposed to COVID-19, and to please contact the box office for refunds or exchanges.

All of our performers, technicians, and staff members are required to be fully vaccinated and masked unless they are onstage performing. Additionally, they are participating in an active testing regimen to keep everyone as safe as possible.

HERE reserves the right to revise protocols as the rate of transmission changes and in light of new scientific data that may present itself.